Black Rock Inc. Harpoon Therapeutics, Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.55 - $0.82 $30,818 - $45,947	-56,033 Reduced 13.13%	370,753 $263,000
Q1 2023 May 12, 2023	SELL	$0.65 - $1.37 $100,189 - $211,167	-154,137 Reduced 26.53%	426,786 $315,000
Q4 2022 Feb 13, 2023	SELL	$0.6 - $1.41 $199,814 - $469,563	-333,024 Reduced 36.44%	580,923 $424,000
Q3 2022 Nov 14, 2022	SELL	$0.94 - $2.56 $24,936 - $67,911	-26,528 Reduced 2.82%	913,947 $886,000
Q2 2022 Aug 12, 2022	SELL	$1.78 - $5.02 $1.55 Million - $4.36 Million	-869,211 Reduced 48.03%	940,475 $1.8 Million
Q1 2022 May 12, 2022	BUY	$3.54 - $8.08 $337,556 - $770,468	95,355 Added 5.56%	1,809,686 $8.99 Million
Q4 2021 Feb 10, 2022	SELL	$5.69 - $7.83 $107,262 - $147,603	-18,851 Reduced 1.09%	1,714,331 $12.9 Million
Q3 2021 Nov 09, 2021	BUY	$7.88 - $14.0 $156,701 - $278,404	19,886 Added 1.16%	1,733,182 $13.7 Million
Q2 2021 Aug 11, 2021	BUY	$13.81 - $23.25 $23.7 Million - $39.8 Million	1,713,296 New	1,713,296 $23.8 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.